AngioDynamics is a leading of medical devices used by interventional radiologists, nephrologists, and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's product line includes market-leading radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.

TypePublic
HQLatham, US
Size (employees)1,250 (est)
Websiteangiodynamics.com
AngioDynamics is headquartered in Latham, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at AngioDynamics

James Clemmer

James Clemmer

President and Chief Executive Officer
Michael Greiner

Michael Greiner

Executive Vice President and Chief Financial Officer
Chad Campbell

Chad Campbell

Senior Vice President and General Manager, Vascular Access
Show more

AngioDynamics Office Locations

AngioDynamics has offices in Queensbury, Denmead, Hong Kong, Oakville and in 2 other locations
Latham, US (HQ)
14 Plaza Dr
Queensbury, US
603 Queensbury Ave
Oakville, CA
101 2275 Upper Middle Rd E
Hong Kong, HK
72 Gloucester Rd
Amsterdam-Zuidoost, NL
Margriet Toren 75 Haaksbergweg
Denmead, GB
Falcon Court Forest Rd
Show all (6)
Report incorrect company information

AngioDynamics Financials and Metrics

AngioDynamics Revenue

Embed Graph
AngioDynamics's revenue was reported to be $344.29 m in FY, 2018
USD

Revenue (FY, 2018)

344.3 m

Gross profit (FY, 2018)

176.9 m

Gross profit margin (FY, 2018), %

51.4%

Net income (FY, 2018)

16.3 m

EBIT (FY, 2018)

10.6 m

Market capitalization (20-Sep-2018)

868.3 m

Closing stock price (20-Sep-2018)

23.4

Cash (31-May-2018)

74.1 m

EV

885.8 m
AngioDynamics's current market capitalization is $868.3 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Revenue

354.5 m357 m353.9 m344.3 m

Revenue growth, %

1%(1%)

Cost of goods sold

174.6 m180.1 m179.6 m167.4 m

Gross profit

179.9 m176.9 m174.3 m176.9 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2018

Revenue

83.7 m89.2 m87.4 m86.7 m

Cost of goods sold

40.5 m43.4 m43.9 m44 m

Gross profit

43.2 m45.8 m43.5 m42.7 m

Gross profit Margin, %

52%51%50%49%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Cash

16.1 m18.4 m32.3 m74.1 m

Accounts Receivable

Inventories

61.1 m67.4 m55.4 m48.9 m

Current Assets

152.2 m155.8 m146.3 m168 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2018

Cash

22.1 m15.2 m7.4 m13.8 m14.9 m19.7 m20.3 m19 m21.9 m49.9 m

Inventories

59.2 m60.1 m59.8 m70.4 m75.3 m68.7 m74.3 m70.8 m65.8 m54 m

Current Assets

145.2 m141.6 m140.1 m154.3 m163.4 m157.3 m160 m151.6 m149.4 m152.5 m

PP&E

51.2 m49.7 m43.8 m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2018

Net Income

3.1 m(3.3 m)(43.6 m)16.3 m

Depreciation and Amortization

16.8 m17.9 m18 m23.2 m

Inventories

(5.4 m)(6.2 m)12 m5.7 m

Accounts Payable

Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(426 k)(525 k)4.6 m470 k1.8 m(2.5 m)(757 k)(1.1 m)(489 k)

Depreciation and Amortization

6.1 m12.3 m18.8 m6.7 m14 m22.8 m7.2 m14.4 m21.4 m

Inventories

(3.5 m)(4.4 m)(4.2 m)(9.2 m)(14.1 m)(7.5 m)(6.9 m)(3.5 m)1.5 m

Cash From Operating Activities

7.3 m15.8 m15.2 m5.4 m3.2 m15.4 m4.7 m14.3 m26.7 m
USDY, 2018

EV/EBIT

83.9 x

EV/CFO

21.5 x

Revenue/Employee

275.4 k

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

AngioDynamics Online and Social Media Presence

Embed Graph
Report incorrect company information

AngioDynamics News and Updates

AngioDynamics to pay $12.5 mln over false claims allegations -U.S. Justice Dept

AngioDynamics Inc has agreed to pay the U.S. government $12.5 million to resolve allegations it caused healthcare providers to submit false claims to federal healthcare programs over the use of two medical devices, the Justice Department said on Wednesday.

Iv Equipment Market to Exceed US$ 12 Bn in 2022

IV Equipment Market to Have a Value of More than US$ 12 Billion by 2022; Europe and North America the Largest Regions Posted via Industry Today. Follow us on Twitter @IndustryToday

Angiographic Catheters Market Forecast Report Offers Actionable Insights

Angiographic Catheters Market Forecast Report Offers Actionable Insights Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

AngioDynamics Company Life and Culture

Report incorrect company information